c-KIT Mutation Analysis, Cell Based

Understand what c-KIT Mutation Analysis, Cell Based signals

LOINC codes: 31208-2, 55201-8
Commercial laboratory assays: 1

We have not added a physiological summary for this biomarker yet. Compare the commercial laboratory assays and population reference ranges below.

Compare commercial laboratory assays for c-KIT Mutation Analysis, Cell Based

Check orderable catalog codes, specimen types, fasting requirements, and demographic reference ranges across laboratories.

c-KIT Mutation Analysis, Cell Based

Laboratory: Quest Diagnostics
Test code: 19961
Specimen: Blood
Fasting: Not stated
LOINC: 31208-2, 55201-8
Turnaround: Set up: Mon

Laboratory assay overview

Activating c-KIT mutations have been indentified in various human cancers. c-KIT exon 8 and 17 mutations have been described in patients with CBF-AMLs and usually confer a poor prognosis with increased relapse rate. c-KIT exon 9, 11, 13, 17 mutations have been reported in nearly 90% GIST patients. The presence mutation usually predict poor survival. c-KIT exon 17 mutation has been reported in patients with systemic mastocytosis.

View complete laboratory reference notes

Not detected

Quest Diagnostics test directory, test code 19961

Verify these ranges and sources

We compile every detail above directly from named laboratory directories and published clinical studies. Laboratories calculate standard reference intervals from the statistical distribution of tested populations for a specific assay method and demographic group, rather than setting universal optimal targets.

Always review your personal lab results with a licensed clinician, or track your lab history and health goals in Aumnivida.

Spotted an error? Email hello@biomarkerlens.com with the page URL and the primary source that corrects the entry.